Drawing for HUMICOR

USPTO serial 78217423

HUMICOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
JENKINS JR, CHARLES L
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HUMICOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald A. Sandler

Lawrence E. Abelman Abelman Frayne & Schwab150 East 42nd StreetNew York, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances, namely, allergy medications, analgesics, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, anticoagulants, antidepressants, antihistamines, bronchodialators, cardiovascular pharmaceuticals, clinical medical reagents, decongestant tablets, expectorants, haemoglobin, hormones, hydrocortisone, medicated lozenges, migraine treatment preparations, muscle relaxants, nasal spray preparations, nausea treatment preparations, pain relief medication, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for use in chemotherapy, vaccines, anti-convulsants, gastrointestinal medications, pharmaceutical preparations for the treatment of bone disorders, central nervous system disorders or shock and cough treatment preparationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2008MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jul 16, 2008ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jul 16, 2008OP.TOPPOSITION TERMINATED NO. 999999—
Jul 16, 2008OP.SOPPOSITION SUSTAINED NO. 999999—
Aug 10, 2006MAILPAPER RECEIVED—
Feb 7, 2006MAILPAPER RECEIVED—
Dec 7, 2004OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 21, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 7, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 8, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 19, 2004NPUBNOTICE OF PUBLICATION—
Mar 18, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2004MAILPAPER RECEIVED—
Jan 12, 20041.BDSec. 1(B) CLAIM DELETED—
Jan 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 10, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance